Literature DB >> 16715690

Risk factors for developing leprosy--a population-based cohort study in Indonesia.

Mirjam I Bakker1, Mochammad Hatta, Agnes Kwenang, Petra Van Mosseveld, William R Faber, Paul R Klatser, Linda Oskam.   

Abstract

We identified risk factors associated with increased yearly incidence rates of leprosy in five island populations. Age, sex, household size and Mycobacterium leprae-specific antibodies as well as contact factors were studied. Of 94 index patients (patients diagnosed in 2000), 43 (46%) were classified as multibacillary (MB), 17 (19%) were seropositive for PGL-1 [corrected] antibodies and 6 (7%) had M. leprae DNA in nasal swabs as determined by polymerase chain reaction (PCR) testing. All PCR positive patients were also seropositive. Forty-four of 4903 initially symptom free persons developed leprosy within 4 years, giving an incidence rate of 298 per 1000 person-years. Men had a 22 times higher risk [95% confidence interval (CI): 1.2-4.1] of developing leprosy than women. People living in households with more than 7 members had a 3.1 times higher risk (95% CI: 1.3-7.3) than households of 1-4 members. Persons who were seropositive in 2000 had a 3.8 times higher risk (95% CI: 1.1-12.6) than seronegative persons. Household contacts of MB patients had an adjusted hazard ratio (aHR) of 4.6 (95% CI: 1.6-12.9) and household contacts of PCR positive patients an aHR of 9.36 (95% CI: 2.5-34.9) compared with non-contacts. Patients with PCR positive nasal swabs, suggesting nasal excretion of M. leprae, are probably the patients with the highest transmission potential. Since all index patients who were PCR positive were also seropositive, serology seems an adequate tool to identify these patients. Preventing seropositive persons from becoming seropositive and infectious patients might break the chain of transmission.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715690

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  31 in total

1.  Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy.

Authors:  L H Sampaio; A L M Sousa; M C Barcelos; S G Reed; M M A Stefani; M S Duthie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-12       Impact factor: 3.267

Review 2.  Leprosy in the 21st century.

Authors:  Cassandra White; Carlos Franco-Paredes
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

3.  Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.

Authors:  R M Oliveira; E M Hungria; A de Araújo Freitas; A L O M de Sousa; M B Costa; S G Reed; M S Duthie; M M A Stefani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-12       Impact factor: 3.267

Review 4.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

Review 5.  Leprosy and the human genome.

Authors:  Elizabeth A Misch; William R Berrington; James C Vary; Thomas R Hawn
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

6.  Geographic information systems and applied spatial statistics are efficient tools to study Hansen's disease (leprosy) and to determine areas of greater risk of disease.

Authors:  José Wilton Queiroz; Gutemberg H Dias; Maurício Lisboa Nobre; Márcia C De Sousa Dias; Sérgio F Araújo; James D Barbosa; Pedro Bezerra da Trindade-Neto; Jenefer M Blackwell; Selma M B Jeronimo
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

7.  Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosis.

Authors:  Malcolm S Duthie; Marah N Hay; Cecile Z Morales; Lauren Carter; Raodoh Mohamath; Lucia Ito; Luiza K M Oyafuso; Marli I P Manini; Marivic V Balagon; Esterlina V Tan; Paul R Saunderson; Steven G Reed; Darrick Carter
Journal:  Clin Vaccine Immunol       Date:  2009-12-16

8.  Antigen-specific T-cell responses of leprosy patients.

Authors:  Malcolm S Duthie; Wakako Goto; Greg C Ireton; Stephen T Reece; Lucas H Sampaio; A B Grassi; Ana Lucia M Sousa; Celina M T Martelli; Mariane M A Stefani; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2008-09-10

9.  Use of protein antigens for early serological diagnosis of leprosy.

Authors:  Malcolm S Duthie; Wakako Goto; Greg C Ireton; Stephen T Reece; Ludimila P V Cardoso; Celina M T Martelli; Mariane M A Stefani; Maria Nakatani; Robson Crusue de Jesus; Eduardo M Netto; Ma V F Balagon; Esterlina Tan; Robert H Gelber; Yumi Maeda; Masahiko Makino; Dan Hoft; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2007-09-26

10.  Early Revelation of Leprosy in China by Sequential Antibody Analyses with LID-1 and PGL-I.

Authors:  Pan Qiong-Hua; Zheng Zhong-Yi; Yang Jun; Wen Yan; Yuan Lian-Chao; Li Huan-Ying; Steven G Reed; Malcolm S Duthie
Journal:  J Trop Med       Date:  2013-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.